![[PDF]](/pb-assets/Icons/adobe-pdf-icon-1498649896243.png){kind=icon}
Abstract
BACKGROUND:
A previous study suggested that high concentrations of endotoxin may be present in whole-cell diphtheria/tetanus/pertussis (DTP) vaccine, and the scientific literature contains many studies examining the reactivity of whole-cell DTP vaccine. The medical and scientific communities have previously reported that the presence of endotoxin in commercial vaccines may have negative effects on vaccine recipients.
OBJECTIVE:
To determine the endotoxin concentrations in whole-cell DTP, acellular DTP (DTaP), and DT vaccines and determine the clinical experience with each vaccine.
METHODS:
To study the endotoxin concentrations in vaccines, the Limulus amebocyte lysate (LAL) assay was used. The vaccines analyzed with the LAL assay were whole-cell DTP vaccine lots manufactured by Connaught, Lederle, the Michigan and Massachusetts Departments of Health, and Wyeth; DTaP vaccine lots manufactured by Merieux and Takeda; and DT vaccine lots manufactured by Wyeth and Lederle. The incidence of adverse reactions following whole-cell DTP, DTaP, and DT vaccines were determined based on analysis of the Vaccine Adverse Events Reporting System (VAERS) database.
RESULTS:
The results of the LAL assay showed that whole-cell DTP vaccines contained considerably more endotoxin than either DTaP or DT vaccines. The VAERS showed that statistically significantly more adverse reactions were associated with whole-cell DTP vaccine than DTaP or DT vaccines.
CONCLUSIONS:
This analysis confirmed higher concentrations of endotoxin in whole-cell DTP vaccines compared with DTaP or DT vaccines. As high concentrations of endotoxin may be correlated with a higher incidence of adverse events, the switch from whole-cell DTP to DTaP for routine vaccinations in the US seems well justified.
References
| 1. |
Geier, MR, Stanbro, H, Merril, CR. Endotoxins in commercial vaccines. Appl Environ Bio 1978;36: 445–9. Google Scholar | Crossref | Medline | ISI |
| 2. |
Geier, DA, Geier, MR. The history of pertussis vaccination: A sordid legacy? J Hist Med Allied Sciences (in press 2002). Google Scholar |
| 3. |
Felton, HM, Verwey, WF. The epidemiological value of a non-cellular pertussis antigen. Pediatrics 1953;16: 637–50. Google Scholar | ISI |
| 4. |
Strom, J . Is universal vaccination against pertussis always justified? BMJ 1960;2: 1184–6. Google Scholar | Crossref | Medline |
| 5. |
Haire, M, Dane, DS, Dick, G. Reactions to combined vaccines containing killed Bordetella pertussis. The Medical Officer 1967;117: 55–8. Google Scholar |
| 6. |
Kulenkamff, M, Schwartzman, JS, Wilson, J. Neurological complications of pertussis inoculation. Arch Dis Child 1974;49: 46–9. Google Scholar | Crossref | Medline | ISI |
| 7. |
Bajc, OTS . Convulsions after pertussis vaccination. Schweiz Med Wschr 1971;110: 1965–71. Google Scholar |
| 8. |
Torch, WC . Diphtheria-pertussis-tetanus (DPT) immunization: A potential cause of sudden infant death syndrome (SIDS) (abstract). Neurology 1982;32:A169–70. Google Scholar | Medline | ISI |
| 9. |
Pittman, M . The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis 1984;3: 467–86. Google Scholar | Crossref | Medline |
| 10. |
US Institute of Medicine . New vaccine development: establishing priorities. Washington, DC: National Academy Press, 1985. Google Scholar |
| 11. |
Ibsen, P, Moller, S, Heron, I. Lipopolysaccharides in a traditional pertussis vaccine. J Biol Stand 1988;16: 299–309. Google Scholar | Crossref | Medline |
| 12. |
US Institute of Medicine . Adverse effects of pertussis and rubella vaccines. Washington, DC: National Academy Press, 1991. Google Scholar |
| 13. |
Alderslade, R, Bellman, MH, Rawson, NSB, Ross, EM. Whooping cough. London: HM Stationary Office, 1981: 79–169. Google Scholar |
| 14. |
Miller, D, Madge, N, Diamond, J, Wadsworth, J, Ross, EM. Pertussis immunization and serious acute neurological illnesses in children. BMJ 1993;307: 1171–6. Google Scholar | Crossref | Medline |
| 15. |
US Institute of Medicine . DPT vaccine and chronic nervous system dysfunction: a new analysis. Washington, DC: National Academy Press, 1994. Google Scholar |
| 16. |
Braun, MM, Mootrey, GT, Salive, ME, Chen, RT, Ellenberg, SS. Infant immunization with acellular pertussis vaccines in the United States: Assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS) (abstract). Pediatrics 2000;106:E51. Google Scholar | Crossref | Medline | ISI |
| 17. |
Geier, MR, Geier, DA. Hepatitis B vaccine and gastroenterologic adverse reactions (letter). Hepatogastroenterology 2001;48:37. Google Scholar | Medline |
| 18. |
Geier, MR, Geier, DA. Arthritic reactions and hepatitis B vaccination: An analysis of the vaccine adverse events reporting system (VAERS) from 1990 through 1997 (letter). Clin Exp Rheumatol 2000;18: 789–90. Google Scholar | Medline | ISI |
| 19. |
Geier, MR, Geier, DA. Immunological reactions and hepatitis B vaccine (letter). Ann Intern Med 2001;134:1155. Google Scholar | Crossref | Medline | ISI |
| 20. |
Geier, DA, Geier, MR. Hepatitis B vaccination and adult associated gastrointestinal reactions: A followup analysis. Hepatogastroenterology (in press 2002). Google Scholar |
| 21. |
Geier, DA, Geier, MR. Hepatitis B vaccination and arthritic adverse reactions: A followup analysis of the vaccine adverse events reporting system (VAERS) database (letter). Clin Exp Rheumatol 2002;20:119. Google Scholar | Medline | ISI |
| 22. |
Geier, MR, Geier, DA. Immunological reactions and hepatitis B vaccine (letter). Ann Intern Med (in press). Google Scholar |
| 23. |
Geier, MR, Geier, DA. Hepatitis B vaccination safety. Ann Pharmacother 2002;36: 370–4. Google Scholar | SAGE Journals | ISI |
| 24. |
Geier, DA, Geier, MR. An analysis of the reactivity of vaccines administered in the state of Texas from 1991 through 1999: Based upon the vaccine adverse events reporting system (VAERS) database. Texas Med (in press 2002). Google Scholar |
| 25. |
Geier, DA, Geier, MR. Rubella vaccine and arthritic adverse reactions: An analysis of the vaccine adverse events reporting system (VAERS) database from 1991 through 1998. Clin Exp Rheumatol 2001;19: 724–6. Google Scholar | Medline | ISI |
| 26. |
Geier, DA, Geier, MR. Anthrax vaccination and joint related adverse reactions in light of biological warfare scenarios. Clin Exp Rheumatol 2002;20(in press). Google Scholar | ISI |
| 27. |
Eckman, PL . Studies on the blood brain barrier. Am J Pathol 1958;34: 631–43. Google Scholar | Medline | ISI |
| 28. |
Iwasa, S, Ishida, K, Akuma, K. Swelling in the brain in mice caused by pertussis vaccine — Its quantitative determination and the responsible factors in the vaccine. Jpn J Med Sci Biol 1985;38: 53–65. Google Scholar | Crossref | Medline |
| 29. |
Homma, R, Kuratsuka, K, Shimazaki, Y, Funasaka, I. The partial purification and some biological activities of histamine sensitizing factor from Bordetella pertussis. Jpn J Med Sci Biol 1970;23: 277–81. Google Scholar | Medline |
| 30. |
Bergman, RK, Munoz, JJ. Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability. J Allergy Clin Immunol 1975;55: 378–85. Google Scholar | Crossref | Medline | ISI |
| 31. |
Linthicum, DS, Munoz, JJ, Blaskett, A. Acute experimental autoimmune encephalomyelitis in mice. Cell Immunol 1982;73: 299–310. Google Scholar | Crossref | Medline | ISI |
| 32. |
Sidey, FM, Furman, BL, Wardlaw, AC. Effect of hyperreactivity to endotoxin on the toxicity of pertussis vaccine and pertussis toxins in mice. Vaccine 1989;7: 237–41. Google Scholar | Crossref | Medline | ISI |
